The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
most of the lipid I'll just release we're somewhat schooled on fibrates are gonna use it in people where the triglyceride parameter is still high because they're assuming I think if we had better metrics of triglyceride rich lipoproteins maybe VLDL remnants or people who have high LDL tried Cerreta levels and they would likely be people who have a possi 3 on their LDLs we have some other evidence that I want to fibrate on board you or so so that's where that's gonna get used
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.